ClinicalTrialsFinder

Immune-related Adverse Event Clinical Trials in London, Ontario

1 recruitingLondon, Ontario, Canada

Showing 1–1 of 1 trials

Recruiting
Phase 2

Early Adalimumab Induction for Immune Checkpoint Inhibitor Associated Inflammatory Arthritis

Immune-related Adverse EventInflammatory Arthritis
Tom Appleton30 enrolled1 locationNCT06037811